{"id":"W2804885025","doi":"10.1177/1756286418774338","title":"Phase IV study of retention on fingolimod <i>versus</i> injectable multiple sclerosis therapies: a randomized clinical trial","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Novartis Pharmaceuticals Corporation","keywords":"Fingolimod; Medicine; Multiple sclerosis; Randomized controlled trial; Natalizumab; Relapsing remitting; Clinical trial; Internal medicine; Oncology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004811453,0.002109558,0.003544842,0.0005034035,0.0005738398,0.001345876,0.00123718,0.002331665,0.007203131],"category_scores_gemma":[0.003051906,0.0008863042,0.001911336,0.0004787343,0.001540409,0.001150862,0.0004781781,0.003163628,0.001281888],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008004348,"about_ca_system_score_gemma":0.001644527,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006865858,"about_ca_topic_score_gemma":0.0009989005,"domain_scores_codex":[0.9983144,0.001043895,0.00009378723,0.0002613131,0.0001172532,0.000169453],"domain_scores_gemma":[0.9975474,0.0007956634,0.0006210423,0.0002185011,0.0001792521,0.0006381499],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9837496,0.008513383,0.0002804201,0.0002369759,0.000447793,0.00001675892,0.00002811252,0.0001457058,0.00167336,0.00004919392,0.0003366159,0.004522165],"study_design_scores_gemma":[0.9526385,0.04591533,0.0004809917,0.00001398472,0.0001712711,0.00001233139,0.000006757482,0.0002762113,0.0002033805,0.0000601674,0.0002142431,0.000006808215],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9790224,0.002508364,0.001188503,0.0008569369,0.0007777526,0.01233568,0.001196843,0.0001970005,0.00191655],"genre_scores_gemma":[0.9707587,0.002360058,0.003655962,0.001952269,0.001133083,0.01532924,0.001428429,0.00005496719,0.003327392],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007203131,"threshold_uncertainty_score":0.0254457,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1835123173007922,"score_gpt":0.4296725863407087,"score_spread":0.2461602690399164,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}